Trisalus Life Sciences, Inc. · NASDAQ:TLSI
Stevens Jennifer sold 316 Trisalus Life Sciences, Inc. shares (Form 4)
Traded Oct 5, 2026 · Filed Oct 7, 2026
On Oct 5, 2026, Stevens Jennifer (Chief Regulatory Officer) sold 316 Trisalus Life Sciences, Inc. shares at US$4.39 for US$1,387, leaving 123,794 shares. Filed Oct 7, 2026 (Form 4).
- Sold
- 316 shares
- Price
- US$4.39
- Value
- US$1,387
- Holding after
- 123,794 shares
- Trading plan
- No
- Role
- Chief Regulatory Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Common Stock | Sale | 316 | US$4.39 | 123,794 | Direct |